作者: Rand Alattar , Tawheeda B. H. Ibrahim , Shahd H. Shaar , Shiema Abdalla , Kinda Shukri
DOI: 10.1002/JMV.25964
关键词:
摘要: Abstract Tocilizumab, an interleukin‐6 inhibitor, may ameliorate the inflammatory manifestations associated with severe coronavirus disease 2019 (COVID‐19) and thus …